Back

How to apply guidelines to clinical practice.

28 August 2016 (12:50 - 13:15)
Organised by:
Congress Presentation Part of: Potent P2Y12 receptor inhibition – What can we learn from clinical practice? Thrombosis and platelets ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Andreas Schaefer

Hannover Medical School, Hannover (Germany)

3 More presentations in this session

Presentation thumbnail
Welcome & introduction: Potent P2Y12 receptor inhibition – What can we learn from clinical practice?
Professor K. Huber (Vienna, AT)
Presentation thumbnail
Optimising P2Y12 inhibition in real world clinical practice: clinical outcomes of prasugrel and ticagrelor.
Professor J. Jukema (Leiden, NL)
Presentation thumbnail
Discussion – Summary and closing remarks: potent P2Y12 receptor inhibition – What can we learn from clinical practice?
Professor K. Huber (Vienna, AT)

Access the full session

Session thumbnail
Potent P2Y12 receptor inhibition – What can we learn from clinical practice?

The Event

Event poster

ESC Congress 2016

28 August 2016 12:50 CET
You may be interested in
thumbnail
Congress Session
Breaking the barriers in guideline-directed medical therapy implementation in heart failure
20 May 2025
thumbnail
Congress Presentation
Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program
27 August 2021
thumbnail
Congress Presentation
Diagnosis and management of acute and subacute CVDs in patients with active cancer.
27 August 2022
thumbnail
Webinar
ESC Webinar : New 2018 Arterial Hypertension guidelines: which cut-off for which patient?
26 September 2018

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources